Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
0(0%)
Results Posted
15%(2 trials)

Phase Distribution

Ph not_applicable
3
15%
Ph phase_1
3
15%
Ph phase_3
7
35%
Ph phase_4
3
15%
Ph phase_2
2
10%

Phase Distribution

3

Early Stage

2

Mid Stage

10

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
3(16.7%)
Phase 2Efficacy & side effects
2(11.1%)
Phase 3Large-scale testing
7(38.9%)
Phase 4Post-market surveillance
3(16.7%)
N/ANon-phased studies
3(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

13 of 13 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

20

all time

Status Distribution
Active(2)
Completed(13)
Other(5)

Detailed Status

Completed13
unknown5
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
20
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (16.7%)
Phase 22 (11.1%)
Phase 37 (38.9%)
Phase 43 (16.7%)
N/A3 (16.7%)

Trials by Status

completed1365%
not_yet_recruiting210%
unknown525%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT03308448Phase 3

Traumatic Optic Neuropathy Treatment Trial 2

Completed
NCT05907499Phase 3

Decitabine for Poor Graft Function Post Allo-HSCT

Not Yet Recruiting
NCT05669079Phase 3

Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT

Not Yet Recruiting
NCT05833477Not Applicable

Tracing Changed Production of Red Blood Cells

Completed
NCT03683810Phase 1

The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia

Unknown
NCT02745990Not Applicable

Recombinant Human Erythropoietin Improve Neurodevelopmental Outcomes in Extremely Preterm Infants

Unknown
NCT04910594Phase 3

Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma

Unknown
NCT04959578Phase 4

Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease

Completed
NCT02076373Phase 3

Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants

Unknown
NCT00413946Phase 2

Does Erythropoietin Improve Outcome in Very Preterm Infants?

Completed
NCT03303573

Safety and Efficacy of Multiple EPO Injections in Children With Cerebral Palsy

Completed
NCT02036073Phase 4

Effect of Erythropoietin on Preterm Brain Injury

Completed
NCT00910858Phase 1

A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes

Completed
NCT01369732Phase 4

Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest

Completed
NCT01320449Not Applicable

Identification of New Serum Markers for Detection of Abuse With Erythropoietin

Completed
NCT00265486

Can Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?

Unknown
NCT00144495Phase 3

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Completed
NCT00144482Phase 3

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Completed
NCT00808704Phase 1

Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy

Completed
NCT00120692Phase 2

Treatment for Patients Suffering From Anemia Due to Chemotherapy

Completed

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20